Ambu A/S
OTC:AMBFF

Watchlist Manager
Ambu A/S Logo
Ambu A/S
OTC:AMBFF
Watchlist
Price: 12.75 USD -6.93%
Market Cap: 3.4B USD

Ambu A/S
Net Income (Common)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Ambu A/S
Net Income (Common) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Ambu A/S
CSE:AMBU B
Net Income (Common)
kr609m
CAGR 3-Years
87%
CAGR 5-Years
20%
CAGR 10-Years
N/A
GN Store Nord A/S
CSE:GN
Net Income (Common)
kr676m
CAGR 3-Years
0%
CAGR 5-Years
-12%
CAGR 10-Years
-1%
Demant A/S
CSE:DEMANT
Net Income (Common)
kr2.3B
CAGR 3-Years
-1%
CAGR 5-Years
23%
CAGR 10-Years
5%
V
ViroGates A/S
CSE:VIRO
Net Income (Common)
-kr12.4m
CAGR 3-Years
-1%
CAGR 5-Years
10%
CAGR 10-Years
N/A
No Stocks Found

Ambu A/S
Glance View

Market Cap
3.4B USD
Industry
Health Care

Ambu A/S, a Danish company rooted in innovation, has carved a niche in the global healthcare sector through its specialized medical devices. Founded in 1937, Ambu started with a simple mission of improving patient care and has stayed true to that vision by continuously advancing their portfolio. The company's journey began with the invention of the resuscitator bag, a revolutionary product that remains a staple in emergency and hospital settings today. Over the years, Ambu has focused strategically on three main segments: Anesthesia, Patient Monitoring & Diagnostics, and Visualisation, each playing a crucial role in the broader healthcare ecosystem. These segments allow Ambu to develop devices that enhance diagnostic procedures, improve safety, and increase efficiency in medical settings, ultimately saving lives and optimizing healthcare delivery. Ambu’s business model capitalizes primarily on innovation-driven sales, with a strong emphasis on disposable medical devices which are gaining popularity due to hygiene concerns and regulatory trends favoring single-use technologies. These products include their flagship single-use endoscopes, marketed under the brand name "Ambu aScope," which significantly reduce the risk of cross-contamination while providing high-quality diagnostic images. The company's revenue model is built on a B2B approach, dealing directly with hospitals, clinics, and other healthcare providers, ensuring a steady flow of sales through long-term contracts and partnerships. Through constant reinvestment into R&D and strategic acquisitions, Ambu sustains its market leadership, driving growth by addressing the evolving needs of the healthcare industry and setting standards in patient care solutions globally.

AMBFF Intrinsic Value
17 USD
Undervaluation 25%
Intrinsic Value
Price

See Also

What is Ambu A/S's Net Income (Common)?
Net Income (Common)
609m DKK

Based on the financial report for Sep 30, 2025, Ambu A/S's Net Income (Common) amounts to 609m DKK.

What is Ambu A/S's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
20%

Over the last year, the Net Income (Common) growth was 159%. The average annual Net Income (Common) growth rates for Ambu A/S have been 87% over the past three years , 20% over the past five years .

Back to Top